✦ LIBER ✦

Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

✍ Scribed by Michael H. Barnett; John W. Prineas

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 751 KB
Volume: 55
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.20016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natalizumab prevents the accumulation of

Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report

✍ F. Rinaldi; M. Calabrese; D. Seppi; M. Puthenparampil; P. Perini; P. Gallo 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 150 KB

Experimental therapy of relapsing–remitt

Experimental therapy of relapsing–remitting multiple sclerosis with copolymer-1

✍ Dr Kenneth P. Johnson 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

After steroid therapy was shown to have some effect on multiple sclerosis (MS) in the early 1970s, the next drug that began to excite interest was copolymer-1 (COP-l), a treatment that was shown to inhibit experimental allergic encephalomyelitis (EM) in several mammalian species. We are now coming t

Interferon-β treatment and the natural h

Interferon-β treatment and the natural history of relapsing-remitting multiple sclerosis

✍ Marcus Koch; Jop Mostert; Jacques De Keyser; Helen Tremlett; Graziella Filippini 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 1 views

Fluctuations of CD4+ T-cell subsets in r

Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis

✍ Dr. Lynn Massman Rose; Arthur H. Ginsberg; Ted L. Rothstein; Jeffrey A. Ledbette 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 819 KB

Defining the response to interferon-β in

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

✍ Jordi Río; Carlos Nos; Mar Tintoré; Nieves Téllez; Ingrid Galán; Raúl Pelayo; Ma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Comparison of interferon beta products a

Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis

✍ M. Etemadifar; M. Janghorbani; V. Shaygannejad 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 264 KB